Of note, the activity of LCAT was reported to be elevated in MASLD, as inferred from a Fatty Liver Index > 60 [25], and Lp-PLA2 levels were found increased in MASLD patients [26]. The gene discussed is LCAT; the disease is metabolic dysfunction-associated steatotic liver disease.